Market Tracker

02/27 5:16pm ET

Agenus Inc (NASDAQ:AGEN)

4.22
Delayed Data
As of 3:59pm ET
 +0.375 / +9.75%
Today’s Change
2.73
Today|||52-Week Range
7.49
+2.43%
Year-to-Date
Agenus (AGEN): What's Ahead for the Stock in Q4 Earnings?
7:02pm / Zacks.com - Paid Partner Content
Why Agenus Stock Is Surging Today
Feb 14 / MotleyFool.com - Paid Partner Content
Troubling Trial Data Weighed on Agenus Inc Stock Today
Feb 22 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.85
Today’s open3.85
Day’s range3.85 - 4.25
Volume2,017,751
Average volume (3 months)1,298,604
Market cap$334.5M
Dividend yield--
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-28.50%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc+0.03+1.27%
VYGRVoyager Therapeutics...+0.65+5.29%
GERNGeron Corp+0.05+2.33%
BLCMBellicum Pharmaceuti...+0.66+5.48%
Data as of 4:00pm ET, 02/27/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
VP-Finance &
Principal Accounting Officer
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts